⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niacinamide SCHEMBL2926 | 1.00 | — | — | |
| Niacinamide SCHEMBL460466 | 1.00 | F7 (1.00) | — | |
| Niacinamide SCHEMBL29624874 | 1.00 | — | — | |
| Niacinamide SCHEMBL1063189 | 0.98 | F7 (0.96) | — | |
| Niacinamide SCHEMBL2271609 | 0.98 | F7 (0.96) | — | |
| Niacinamide SCHEMBL25366418 | 0.98 | — | — | |
| Niacinamide SCHEMBL9064246 | 0.98 | F7 (0.96) | — | |
| Niacinamide SCHEMBL11410594 | 0.98 | F7 (0.96) | — | |
| Niacinamide SCHEMBL6478235 | 0.98 | F7 (0.96) | — | |
| Niacinamide SCHEMBL13935083 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 703 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171489-B1 | SANITIZING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2026-03-25 | — | — | EP | claimed |
| EP-4593790-B1 | MILD WASH COMPOSITION WITH BIODEGRADABLE THICKENER AND ENHANCED MICROBIOTA IMPACT | UNILEVER IP HOLDINGS B V (NL) | 2026-03-18 | — | — | EP | claimed |
| EP-4347050-B1 | METHOD FOR COSMETIC TREATMENT BY COMBINED ILLUMINATION AND APPLICATION OF A COMPOSITION COMPRISING AN EPILOBIUM EXTRACT, AND ASSOCIATED DEVICE | LIGHTINDERM (FR) | 2026-03-04 | — | — | EP | claimed |
| EP-4257112-B1 | SKIN CARE COMPOSITIONS COMPRISING VITAMIN E AND VITAMIN B3 | COLGATE PALMOLIVE CO (US) | 2026-03-04 | — | — | EP | claimed |
| EP-4262528-B1 | DEVICE AND METHOD FOR CONTINUOUS EVEN APPLICATION OF COMPOSITION TO SKIN | KENVUE BRANDS LLC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4504167-B1 | ORAL COMPOSITION CONTAINING DIMETHYLGLYCINE FOR IMPROVING THE CONDITION OF THE HAIR AND SCALP | DR KURT WOLFF GMBH & CO KG (DE) | 2026-02-18 | — | — | EP | claimed |
| EP-3976811-B1 | METABOLOMIC CHARACTERIZATION OF MICROORGANISMS | LEWIS IAN ANDREW (CA) | 2026-02-11 | — | — | EP | claimed |
| EP-4547342-B1 | STABLE WASH COMPOSITION WITH UNSATURATED ZWITTERIONIC SURFACTANT | UNILEVER IP HOLDINGS B V (NL) | 2026-01-28 | — | — | EP | claimed |
| EP-4017496-B1 | FORMULATIONS FOR USE IN THE PREVENTION AND/OR TREATMENT OF PERIPHERAL NEUROPATHY AND ITS ASSOCIATED DISEASES | LOH YIN SZE (SG) | 2026-01-07 | — | — | EP | claimed |
| EP-4661968-A1 | DIHYDROTRIAZINE COMPOUND AND COMPOSITION FOR USE IN PODOLOGY, IN THE PROPHYLAXIS AND/OR TREATMENT OF FOOT DISORDERS, THE TREATMENT OF TATTOOS AND/OR TATTOO WOUNDS AND THE TREATMENT OF A PIERCING AND/OR PIERCING WOUNDS | B. Braun Melsungen AG (DE) | 2025-12-17 | — | — | EP | claimed |
| EP-3068437-B2 | SPRAYABLE TOPICAL CARRIER AND COMPOSITION COMPRISING PHOSPHATIDYLCHOLINE | LIPIDOR AB (SE) | 2022-07-06 | — | — | EP | claimed |
| EP-4011352-A1 | NEW COSMETICS SOLVENTS BASED ON THREE DIFFERENT COMPONENTS | Beiersdorf AG (DE) | 2022-06-15 | — | — | EP | claimed |
| US-11331251-B2 | Method and system for selective hair brightening | XTREAMHAIR LTD. (IL) | 2022-05-17 | — | — | US | claimed |
| EP-3275440-B1 | NOVEL OXADIAZOLE DERIVATIVE AND PHARMACEUTICAL CONTAINING SAME | NAT CT GERIATRICS & GERONTOLOGY (JP) | 2022-05-04 | — | — | EP | claimed |
| EP-3134064-B1 | SCALP CARE COMPOSITION | PROCTER & GAMBLE (US) | 2022-04-13 | — | — | EP | claimed |
| CN-114181144-A | Fluorobiphenyl methyl resorcinol ether derivative, preparation method and application thereof | 浙江工业大学 | 2022-03-15 | — | — | CN | claimed |
| EP-3551627-B1 | NEW ISOXAZOLYL ETHER DERIVATIVES AS GABA A ALPHA5 PAM | HOFFMANN LA ROCHE (CH) | 2022-02-16 | — | — | EP | claimed |
| EP-3622053-B1 | USE OF URIC ACID FOR A CELL CULTURE IN AN AEROBIC ATMOSPHERE NOT SUPPLEMENTED WITH CO2 | FOND MEDITERRANEE INFECTION (FR) | 2022-02-09 | — | — | EP | claimed |
| EP-3778868-B1 | CELL CULTURE MEDIUM FOR CULTIVATING CELLS, METHOD FOR CULTURING CELLS AND METHOD FOR EXPRESSING AT LEAST ONE RECOMBINANT PROTEIN IN A CELL CULTURE | UGA BIOPHARMA GMBH (DE) | 2022-01-26 | — | — | EP | claimed |
| EP-3397749-B1 | LAYERED CELL CULTURE PARTICLES AND METHODS OF MAKING THEREOF | LIFE TECHNOLOGIES CORP (US) | 2022-01-26 | — | — | EP | claimed |